nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
|
Xie, Jie |
|
2017 |
168 |
2 |
p. 389-399 |
artikel |
2 |
A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer
|
Ibrahim, Mohammed F. K. |
|
2017 |
168 |
2 |
p. 371-379 |
artikel |
3 |
Analysis of breast cancer in young women in the Department of Defense (DOD) database
|
Zimmer, Alexandra S. |
|
2017 |
168 |
2 |
p. 501-511 |
artikel |
4 |
A single institution experience with palbociclib toxicity requiring dose modifications
|
Gong, Jun |
|
2017 |
168 |
2 |
p. 381-387 |
artikel |
5 |
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition
|
Santos, E. Santana dos |
|
2017 |
168 |
2 |
p. 311-325 |
artikel |
6 |
Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study
|
Xia, Zhiyu |
|
2017 |
168 |
2 |
p. 443-455 |
artikel |
7 |
Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy
|
Han, S. N. |
|
2017 |
168 |
2 |
p. 551-557 |
artikel |
8 |
CD14+ HLA-DR−/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation
|
Speigl, Lisa |
|
2017 |
168 |
2 |
p. 401-411 |
artikel |
9 |
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
|
Kwan, Marilyn L. |
|
2017 |
168 |
2 |
p. 523-530 |
artikel |
10 |
Characterization of a novel germline BRCA1 splice variant, c.5332+4delA
|
Yang, Ciyu |
|
2017 |
168 |
2 |
p. 543-550 |
artikel |
11 |
Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis
|
Underwood, E. A. |
|
2017 |
168 |
2 |
p. 299-310 |
artikel |
12 |
Comments on “Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors” by Parise CA and Caggiano V, Breast Cancer Res Treat, 2017.
|
Pichilingue-Febres, Alejandra F. |
|
2017 |
168 |
2 |
p. 577-578 |
artikel |
13 |
Correction to: Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors
|
Nomura, Sarah J. O. |
|
2018 |
168 |
2 |
p. 481-482 |
artikel |
14 |
Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors
|
Nomura, Sarah J. O. |
|
2017 |
168 |
2 |
p. 467-479 |
artikel |
15 |
Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy
|
Vulpen, Jonna K. van |
|
2017 |
168 |
2 |
p. 421-431 |
artikel |
16 |
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer
|
du Rusquec, Pauline |
|
2017 |
168 |
2 |
p. 559-566 |
artikel |
17 |
Enrichment of high-grade tumors in breast cancer gene expression studies
|
Seijen, M. van |
|
2017 |
168 |
2 |
p. 327-335 |
artikel |
18 |
Genetic variation in TNFα, PPARγ, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort
|
Duggan, Catherine |
|
2017 |
168 |
2 |
p. 567-576 |
artikel |
19 |
Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work
|
Falandry, Claire |
|
2017 |
168 |
2 |
p. 433-441 |
artikel |
20 |
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
|
Matikas, Alexios |
|
2017 |
168 |
2 |
p. 349-355 |
artikel |
21 |
99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis
|
Wang, Jiwei |
|
2017 |
168 |
2 |
p. 365-370 |
artikel |
22 |
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy
|
Pistilli, B. |
|
2017 |
168 |
2 |
p. 357-364 |
artikel |
23 |
Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer
|
Fang, Hehui |
|
2017 |
168 |
2 |
p. 287-297 |
artikel |
24 |
Predictors of survival for breast cancer patients with a BRCA1 mutation
|
Narod, Steven A. |
|
2017 |
168 |
2 |
p. 513-521 |
artikel |
25 |
PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer
|
Wang, Zhe |
|
2017 |
168 |
2 |
p. 531-542 |
artikel |
26 |
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
|
Blok, Erik J. |
|
2017 |
168 |
2 |
p. 413-420 |
artikel |
27 |
Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
|
Yu, Y. F. |
|
2017 |
168 |
2 |
p. 337-348 |
artikel |
28 |
Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer
|
Reinert, T. |
|
2017 |
168 |
2 |
p. 457-465 |
artikel |
29 |
Weak circadian rhythm increases neutropenia risk among breast cancer patients undergoing adjuvant chemotherapy
|
Li, Wentao |
|
2017 |
168 |
2 |
p. 483-493 |
artikel |
30 |
Worse survival after breast cancer in women with anorexia nervosa
|
Bens, Annet |
|
2017 |
168 |
2 |
p. 495-500 |
artikel |